Birchview Capital, LP 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Birchview Capital, LP disclosed 71 US equity positions worth $100.7m in its Q2 2025 13F filing. The largest position was BMY at 14.9% of the reported book, followed by KLAC and CORT. Against the Q1 2025 filing, it opened 7 new positions, added to 15 and reduced 8 among the top 50 holdings.
What did Birchview Capital, LP own in Q2 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 14.9% | $15.0m | 323,358 | -53% | reduced |
| 2 | KLAC KLA CORPORATION | Technology | 14.1% | $14.2m | 15,848 | – | new |
| 3 | CORT CORCEPT THERAPEUTICS INC | Healthcare | 4.9% | $4.9m | 67,200 | 2% | added |
| 4 | OVV OVINTIV INC | Energy | 4.1% | $4.1m | 107,500 | 106% | added |
| 5 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 4.0% | $4.1m | 187,800 | -29% | reduced |
| 6 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 3.9% | $3.9m | 30,940 | 2% | added |
| 7 | PHR PHREESIA INC | Healthcare | 3.2% | $3.3m | 114,700 | 0% | held |
| 8 | PROTHENA CORP PLC | 2.7% | $2.7m | 451,019 | 35% | added | |
| 9 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 2.6% | $2.7m | 48,000 | -0% | held |
| 10 | STOK STOKE THERAPEUTICS INC | Healthcare | 2.4% | $2.4m | 210,000 | -0% | held |
| 11 | ELUT ELUTIA INC | 2.3% | $2.3m | 1,159,059 | -2% | reduced | |
| 12 | CSTL CASTLE BIOSCIENCES INC | Healthcare | 2.2% | $2.3m | 110,600 | 25% | added |
| 13 | QDELUSD QUIDELORTHO CORP | 2.1% | $2.1m | 72,548 | 7% | added | |
| 14 | EQT EQT CORPORATION | Energy | 2.0% | $2.0m | 34,619 | 0% | held |
| 15 | HROW HARROW HEALTH INC | 1.8% | $1.8m | 60,000 | -18% | reduced | |
| 16 | NVCR NOVOCURE LTD | Healthcare | 1.8% | $1.8m | 101,000 | 226% | added |
| 17 | AXGN AXOGEN INC | Healthcare | 1.7% | $1.7m | 161,000 | 0% | held |
| 18 | BDSX BIODESIX INC | 1.6% | $1.6m | 5,736,113 | 0% | held | |
| 19 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 1.5% | $1.5m | 103,000 | -25% | reduced |
| 20 | FHTX FOGHORN THERAPEUTICS INC | Healthcare | 1.5% | $1.5m | 310,930 | 0% | held |
| 21 | ALKS ALKERMES PLC | Healthcare | 1.4% | $1.4m | 50,000 | 0% | held |
| 22 | MASI* MASIMO CORP | 1.4% | $1.4m | 8,280 | -27% | reduced | |
| 23 | QURE UNIQURE NV | 1.4% | $1.4m | 98,697 | 11% | added | |
| 24 | UTHR UNITED THERAPEUTICS CORP | Healthcare | 1.2% | $1.2m | 4,250 | -43% | reduced |
| 25 | DCGO DOCGO INC | 1.2% | $1.2m | 764,062 | -12% | reduced | |
| 26 | TMCI TREACE MEDICAL CONCEPTS INC | Healthcare | 1.0% | $1.0m | 176,947 | 7% | added |
| 27 | SLDB SOLID BIOSCIENCES INC | Healthcare | 0.9% | $870.6k | 178,768 | 39% | added |
| 28 | KINIKSA PHARMACEUTICALS LTD | 0.8% | $830.1k | 30,000 | -0% | held | |
| 29 | FCX FREEPORT-MCMORAN CL-B | Basic Materials | 0.8% | $781.7k | 18,033 | – | new |
| 30 | 4XC1 KALVISTA PHARMACEUTICALS INC | 0.8% | $757.4k | 67,000 | -0% | held | |
| 31 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 0.7% | $746.6k | 36,000 | – | new |
| 32 | APGE APOGEE THERAPEUTICS INC | Healthcare | 0.7% | $694.9k | 16,000 | 100% | added |
| 33 | OMGBP OUTSET MEDICAL INC | 0.7% | $664.4k | 34,584 | 41% | added | |
| 34 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.7% | $657.3k | 21,000 | 0% | held |
| 35 | RARE ULTRAGENYX PHARMACEUTICAL INC | Healthcare | 0.6% | $654.5k | 18,000 | 12% | added |
| 36 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 0.6% | $626.3k | 6,000 | 0% | held |
| 37 | OLMA OLEMA PHARMACEUTICALS INC | Healthcare | 0.6% | $570.8k | 134,000 | – | new |
| 38 | SRRK SCHOLAR ROCK HOLDING CORP | Healthcare | 0.6% | $566.7k | 16,000 | 0% | held |
| 39 | NTLA INTELLIA THERAPEUTICS INC | Healthcare | 0.6% | $562.8k | 60,000 | – | new |
| 40 | KIDS ORTHOPEDIATRICS CORP | Healthcare | 0.6% | $558.5k | 26,000 | 30% | added |
| 41 | IMNM IMMUNOME INC | Healthcare | 0.6% | $558.0k | 60,000 | – | new |
| 42 | XNCR XENCOR INC | Healthcare | 0.5% | $550.2k | 70,000 | 169% | added |
| 43 | HALO HALOZYME THERAPEUTICS INC | Healthcare | 0.5% | $520.2k | 10,000 | 0% | held |
| 44 | PACB PACIFIC BIOSCIENCES CALIF INC | Healthcare | 0.5% | $496.0k | 400,000 | – | new |
| 45 | INBX INHIBRX BIOSCIENCES INC | 0.5% | $458.2k | 32,110 | 0% | held | |
| 46 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 0.4% | $377.6k | 8,000 | 0% | held |
| 47 | ATEC ALPHATEC HOLDINGS INC | Healthcare | 0.4% | $366.3k | 33,000 | 0% | held |
| 48 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 0.4% | $358.4k | 40,000 | 0% | held |
| 49 | 2655787D BLUEPRINT MEDICINES CORP | 0.3% | $346.1k | 2,700 | 0% | held | |
| 50 | CYTK CYTOKINETICS INC | Healthcare | 0.3% | $330.4k | 10,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.